Arthur Kim Ritchey MD

A. Kim Ritchey, MD is a Professor of Pediatrics and Vice Chair of International Affairs in the Department of Pediatrics. He is a pediatric hematologist-oncologist who has extensive experience caring for children with blood diseases and cancer, participates and leads clinical investigation in the field, and has mentored numerous trainees in the clinical and clinical research settings. He is the departmental representative for all aspects of international activity.

Dr. Ritchey graduated from Dartmouth College, University of Cincinnati School of Medicine, competed pediatric residency at Johns Hopkins Hospital, and fellowship training at Yale University School of Medicine. He was Chief of the Section of Pediatric Hematology/Oncology at West Virginia University School of Medicine and most recently served as the Division Chief of Pediatric Hematology/Oncology at University of Pittsburgh School of Medicine for 14 years.

Dr. Ritchey's clinical and clinical research interests span both oncology and hematology. In the field of oncology, he has served as PI of individualclinical trials and on several clinical trial study committees. He was the local PI for the Pediatric Oncology Group or Children's Oncology Group (COG) forover 25 years. He served on the NCI Pediatric Leukemia and Lymphoma Steering Committee and is Chair of the COG Data Safety Monitoring Committee for Phase 2 and 3 trials.

In the field of hematology, Dr. Ritchey has particularly focused on hemophilia. He has cared for infants and children with hemophilia for over 30 years. He initiated the Comprehensive Hemophilia Clinic at Yale New Haven Hospital and served on the Executive Committee of Region III Federally Funded Hemophilia Treatment Centers for 13 years. Dr. Ritchey is a member of the Board of Directors of the Hemophilia Center of Western Pennsylvania.

Dr. Ritchey has had important roles nationally. He was the President of the American Society of Pediatric Hematology/Oncology andserved on many committees of the Society. He was the Chair of the Subboard of Pediatric Hematology/Oncology of the American Board of Pediatrics and was also appointed to its the Board of Directors.